title: Baseline differences explain the apparent benefits of combining oxymetazoline with intranasal corticosteroids.
authors.forename: Paul B
authors.initials: PB
authors.lastname: Keiser
authors.forename: Michael R
authors.initials: MR
authors.lastname: Nelson
mesh_terms: D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D014663:Nasal Decongestants / Q000008:administration & dosage*; D010109:Oxymetazoline / Q000008:administration & dosage*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
chemical_list: D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D014663:Nasal Decongestants; D010109:Oxymetazoline